CoChat

4-Aminopyridine is a promising treatment option for patients with gain-of-function KCNA2 -encephalopathy

The DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index.

Abstract

4-Aminopyridine is a potential therapeutic option for a subgroup of patients with KCNA2 -encephalopathy and gain-of-function variants.

Overview

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.aaz4957

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 68 references

Research works printed but not linked: 1

  1. M. Msall, S. Braun, C. Granger, Use of the functional independence measure for children (WeeFIM): An interdisciplinary training tape. Dev. Med. Child Neurol. 32, 46–50 (1990).

Cited by

See all 88

Metadata

Authors
Hedrich, U. B. S., Lauxmann, S., Wolff, M., Synofzik, M., Bast, T., Binelli, A., Serratosa, J. M., Martínez-Ulloa, P., Allen, N. M., King, M. D., Gorman, K. M., Zeev, B. B., Tzadok, M., Wong-Kisiel, L., Marjanovic, D., Rubboli, G., Sisodiya, S. M., Lutz, F., Ashraf, H. P., Torge, K., Yan, P., Bosselmann, C., Schwarz, N., Fudali, M., & Lerche, H.
Affiliations
  • Hertie Institute for Clinical Brain Research (DE)
  • Vivantes Klinikum (DE)
  • German Center for Neurodegenerative Diseases (DE)
  • University of Freiburg (DE)
  • Hospital Pedro de Elizalde (AR)
  • Centre for Biomedical Network Research on Rare Diseases (ES)
  • Hospital Universitario Fundación Jiménez Díaz (ES)
  • Ollscoil na Gaillimhe – University of Galway (IE)
  • University College Dublin (IE)
  • Tel Aviv University (IL)
  • Divisions of Child Neurology & Division of Epilepsy, Department of Neurology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.
  • Danish Epilepsy Center, Filadelfia, 4293 Dianalund, Denmark.
  • University of Copenhagen (DK)
  • UCL Queen Square Institute of Neurology (GB)
  • University of Tübingen (DE)
Corresponding author
  • Hedrich, Ulrike B. S.
  • Lauxmann, Stephan
  • Lerche, Holger
Venue
Science Translational Medicine
Published
2021-09
Volume
13
Issue
609
Pages
eaaz4957-eaaz4957
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
OpenAlex
W3196414892
Cited by
87
References
69
Citations by year
2026: 10 · 2025: 24 · 2024: 18 · 2023: 21 · 2022: 11 · 2021: 3
FWCI
4.16
Type
journal article
Language
en
Open access
closed
Locations
  • Science Translational Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • DZNE Pub (submittedVersion)
Funders
National Institute for Health and Care Research
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
  • Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
Keywords
4-aminopyridine, KCNA2, gain-of-function mutations, encephalopathy, potassium channelopathy, treatment selection
MeSH terms
Gain of Function Mutation, Brain Diseases, Epilepsy, Humans, Mutation, 4-Aminopyridine, Kv1.2 Potassium Channel

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 4-Aminopyridine is a promising treatment option for patients with gain-of-function KCNA2 -encephalopathy. https://app.cochat.ai/papers/10.1126/scitranslmed.aaz4957
The paper
Hedrich, U. B. S., Lauxmann, S., Wolff, M., Synofzik, M., Bast, T., Binelli, A., Serratosa, J. M., Martínez-Ulloa, P., Allen, N. M., King, M. D., Gorman, K. M., Zeev, B. B., Tzadok, M., Wong-Kisiel, L., Marjanovic, D., Rubboli, G., Sisodiya, S. M., Lutz, F., Ashraf, H. P., . . . Lerche, H. (2021). 4-Aminopyridine is a promising treatment option for patients with gain-of-function KCNA2 -encephalopathy. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aaz4957

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.